RIA
NVAX icon

Realta Investment Advisors’s Novavax NVAX Stock Holding History

Realta Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,775
Closed -$254K – 453
2021
Q4 		$254K Sell
1,775
-25
-1% -$4.3K 0.06% 351
2021
Q3 		$373K Hold
1,800
– – 0.09% 257
2021
Q2 		$382K Hold
1,800
– – 0.09% 247
2021
Q1 		$326K Hold
1,800
– – 0.09% 262
2020
Q4 		$201K Sell
1,800
-500
-22% -$53.1K 0.06% 311
2020
Q3 		$249K Buy
+2,300
New +$280K 0.08% 256

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Realta Investment Advisors's NVAX Position: Q1 2022 in Review

Realta Investment Advisors sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,775 shares — an estimated $254K sold.

Realta Investment Advisors first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $382K in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Realta Investment Advisors reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Realta Investment Advisors sold 1,775 Novavax shares in Q1 2022, an estimated $254K.
  • Realta Investment Advisors first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
  • Realta Investment Advisors's Novavax position peaked at $382K in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Realta Investment Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.